Article Text
Statistics from Altmetric.com
Footnotes
Contributors All authors were involved in the writing, editing and reviewing the submitted work.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests AJP reports personal fees from ResMed, Philips and Sanofi Genzyme for lecturing; clinical advisory board membership for Philips on the management of COPD. JLP reports grants and personal fees from ResMed, Philips, Agiradom, Astra Zeneca, SEFAM; research support from Mutualia and Air Liquide Foundation; grants from Fisher and Paykel and Vitalaire; he has also received personal fees from JAZZ pharmaceuticals and ITAMAR. NH reports personal fees for lecturing from Philips, Resmed, Fisher-Paykel held by Guy’s and St Thomas’ Charity; unrestricted grants from Philips, Resmed and Fisher Paykel, with the funds held and managed by Guy’s and St Thomas’ NHS Foundation Trust; financial support from Philips for development of the MYOTRACE technology that has patent filed in Europe (US patent pending); membership of the Pulmonary Research Advisory Board for Philips with the funds for this role held by Guy’s and St Thomas’ NHS Foundation Trust; and is Joint Editor-in-Chief for Thorax.
Patient consent for publication Not required.
Provenance and peer review Commissioned; externally peer reviewed.
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.